Results
|
|
2021.
|
|
|
|
2022.
|
|
|
|
2023.
|
|
|
|
2024.
|
|
|
|
2025.
|
|
|
|
2026.
|
|
|
|
2027.
|
Inhibition of MCP-1/CCR2 signaling pathway is involved in synergistic inhibitory effects of irbesartan with rosuvastatin on vascular remodeling. [electronic resource] by
- Ohshima, Kousei
- Mogi, Masaki
- Nakaoka, Hirotomo
- Jing, Fei
- Iwanami, Jun
- Min, Li-Juan
- Tsukuda, Kana
- Kanno, Harumi
- Ogimoto, Akiyoshi
- Higaki, Jitsuo
- Horiuchi, Masatsugu
Producer: 20130516
In:
Journal of the American Society of Hypertension : JASH vol. 6
Availability: No items available.
|
|
|
2028.
|
|
|
|
2029.
|
|
|
|
2030.
|
|
|
|
2031.
|
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism. [electronic resource] by
- Bertolotti, M
- Del Puppo, M
- Corna, F
- Anzivino, C
- Gabbi, C
- Baldelli, E
- Carulli, L
- Loria, P
- Galli Kienle, M
- Carulli, N
Producer: 20130207
In:
Nutrition, metabolism, and cardiovascular diseases : NMCD vol. 22
Availability: No items available.
|
|
|
2032.
|
|
|
|
2033.
|
|
|
|
2034.
|
|
|
|
2035.
|
|
|
|
2036.
|
|
|
|
2037.
|
|
|
|
2038.
|
|
|
|
2039.
|
|
|
|
2040.
|
|